Clinical efficacy of sitafloxacin (200mg daily) against female patients with acute cystitis

Trial Profile

Clinical efficacy of sitafloxacin (200mg daily) against female patients with acute cystitis

Completed
Phase of Trial: Phase III

Latest Information Update: 16 May 2016

At a glance

  • Drugs Sitafloxacin (Primary)
  • Indications Bacterial infections; Cystitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Jul 2014 Planned End Date changed from 12 Mar 2012 to 12 Mar 2013 as reported by University Hospital Medical Information Network - Japan.
    • 27 Jul 2013 Planned End Date added to 12 Mar 2012 as reported by University Hospital Medical Information Network - Japan.
    • 08 Feb 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top